Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023

BUY
$31.15 - $33.39 $354,487 - $379,978
11,380 Added 4991.23%
11,608 $385,000
Q4 2021

Jan 24, 2022

BUY
$17.46 - $21.61 $803 - $994
46 Added 25.27%
228 $5,000
Q3 2021

Oct 29, 2021

BUY
$17.35 - $22.5 $1,058 - $1,372
61 Added 50.41%
182 $4,000
Q2 2021

Aug 02, 2021

BUY
$18.01 - $28.32 $594 - $934
33 Added 37.5%
121 $3,000
Q1 2021

Apr 29, 2021

SELL
$19.76 - $29.89 $237 - $358
-12 Reduced 12.0%
88 $2,000
Q2 2019

Jul 23, 2019

BUY
$10.88 - $17.6 $1,088 - $1,760
100 New
100 $1,000
Q2 2018

Jul 27, 2018

SELL
$13.8 - $16.8 $2,442 - $2,973
-177 Closed
0 $0
Q1 2018

Apr 30, 2018

BUY
$13.8 - $16.2 $2,442 - $2,867
177 New
177 $3,000

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Tci Wealth Advisors, Inc. Portfolio

Follow Tci Wealth Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.